Study: NCT02608320

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl Transdermal System [TDS] Small Patches)
Description: Duragesic 12.5 mcg/h (Treatment A) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New JNJ-35685-AAA-G016 (Fentanyl TDS -Small Patches)
Description: New JNJ-35685-AAA-G016 12.5 mcg/h (Treatment B) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aged JNJ-35685-AAA-G016 (Fentanyl TDS Small Patches)
Description: Aged JNJ-35685-AAA-G016 12.5 mcg/h (Treatment C) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duragesic (Fentanyl TDS Large Patches)
Description: Duragesic 100 mcg/h (Treatment D) in either period 1, 2 or 3 as per treatment sequence, applied to the paraspinal region of the back for 72 hours, applied to the paraspinal region of the back for 72 hours.